| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Legionella massiliensis Campocasso et al. 2012 |
DSM No.: | 24804, Type strain dsm-24804 dsm24804 dsm 24804 Legionella massiliensis |
Strain designation: | LegA, CSUR P146 |
Other collection no. or WDCM no.: | CSUR P146 |
Isolated from: | water from a cooling tower |
Country: | France Bouches du Rhone |
Date of sampling: | 03.2009 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- A. Campocasso, URMITE, Univ. Méditerranée, Marseille, France; LegA |
Genbank accession numbers: | 16S rRNA gene: JF779685 mipgene: JN191171 rpoB gene: JN191175 23S-5S: JN191169 rnpB gene: JN191173 |
Cultivation conditions: | Medium 585 , needs high humidity, 30°C
For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used
Incubation time: 2-3 days
Complete DSMZ Media List |
Summary and additional information: | <- A. Campocasso, URMITE, Univ. Méditerranée, Marseille, France; LegA. Water from a cooling tower; France, Bouches du Rhone. Type strain. Taxonomy/description (17315). Sequence accession no. 16S rRNA gene: JF779685, mipgene: JN191171, rpoB gene: JN191175, 23S-5S: JN191169, rnpB gene: JN191173. (Medium 585, 30°C, needs high humidity). For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used. |
Literature: | 17315 |
Risk group: | 1 (classification according to German TRBA) |
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |